Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary Nerve Growth Factor as a Biomarker for Medical Treatment of Male LUTS
NCT01457573Phase 4Completed
- Start
- Oct 2011
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tamsulosin, solifenacin in lower urinary tract symptoms (LUTS). Started Oct 2011; status: completed.
02
Drugs
tamsulosinsolifenacin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT01457573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01457573.